Streetbeat News

Products Services

ONEQ

SMCI

SOXX

Super Micro Computer Inc. (SMCI) has seen a remarkable 9,900% increase in stock value since its 2007 IPO, significantly outperforming Nvidia and the Philadelphia Semiconductor Index (SOXX) in 2023. With strong financials and an optimistic outlook, Super Micro's revenue guidance has been raised to $14.3-$14.7 billion. The company's focus on AI-optimized computer platforms has contributed to its success, despite a recent pullback after Wells Fargo's cautious rating. BofA Securities initiated coverage with a Buy rating and a $1,040 price target, highlighting the company's potential in the growing AI server market.

Portfolio Pulse from Shanthi Rexaline

February 20, 2024 | 9:50 am

ETHUSD

FLOKIUSD

After Ethereum co-founder Vitalik Buterin tweeted about the potential of AI in finding smart contract bugs, TokenFi's TOKEN, associated with FLOKI, saw a 20% increase in value. TokenFi announced the launch of AI-based products including an AI Smart Contract Auditor. Crypto analyst Scofield predicts TOKEN could surge over 50% to $0.057.

Portfolio Pulse from Mehab Qureshi

February 20, 2024 | 9:02 am

BCRX

BioCryst Pharmaceuticals, Inc. (BCRX) announced the launch of ORLADEYO® in Italy for the prevention of hereditary angioedema (HAE) attacks, following reimbursement and recommendation by the Italian Medicines Agency (AIFA). This marks the availability of the first oral, once-daily therapy for HAE patients in Italy.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 8:48 am

ACN

Accenture (NYSE:ACN) is set to acquire GemSeek, a top customer experience analytics provider. This move is part of Accenture Song's investment in data and AI to enhance client growth and customer relevance.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 8:45 am

CLVT

Clarivate Plc (NYSE:CLVT), a global intelligence provider, has launched the Clarivate Center for IP and Innovation Research. This new unit aims to assist corporations and research organizations in creating innovative ideas and valuable technology and brand IP assets.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 8:44 am

AAPL

Apple Inc.'s Vision Pro mixed reality headset's travel case has sparked mixed reactions online due to its unique design and $199 price tag. The case, designed to protect the Vision Pro headset, features a Ripstop outer shell, Polycarbonate structure, and compartments for accessories. Despite its innovative design, some users criticized its utility and cost, especially since the Vision Pro itself is priced at $3,499 without the case included. Meanwhile, early adopters of the Vision Pro have reported issues with the headset, and competitors like Meta Platforms, Inc. have claimed their products are superior. However, Microsoft executives have shown approval of the Vision Pro.

Portfolio Pulse from Ananya Gairola

February 20, 2024 | 8:28 am

RTX

Pratt & Whitney, a business unit of RTX (NYSE:RTX), has been chosen by Cebu Pacific Air to supply GTF engines for 15 more single-aisle aircraft, including 10 A321neo and 5 A320neo models. Additionally, Pratt & Whitney will offer engine maintenance under an EngineWise Comprehensive service agreement.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 8:24 am

EADSY

Airbus CEO Christian Scherer downplays the threat from China's Comac C919, stating it won't significantly impact the market. Despite the C919's certification and entry into commercial service, Scherer views it as similar to existing Airbus and Boeing models and welcomes the competition. The C919 uses the same engines as the Airbus A320neo and has secured orders from China's Tibet Airlines.

Portfolio Pulse from Benzinga Neuro

February 20, 2024 | 8:17 am

EVLV

Evolv Technology has been selected as the preferred technology provider for patron screening in North America by ASM Global. This partnership highlights Evolv's leadership in advanced screening solutions and ASM Global's dedication to enhancing guest experiences at its venues worldwide.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 8:08 am

ABBV

AbbVie presented new data from its gastroenterology portfolio at the 19th Congress of European Crohn's and Colitis Organisation, showcasing 17 abstracts on treatments for inflammatory bowel diseases. Key presentations included data on risankizumab (SKYRIZI) and upadacitinib (RINVOQ), highlighting their effectiveness and safety in treating ulcerative colitis and Crohn's disease.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 8:04 am